NCT02724488View on ClinicalTrials.gov

Selection Pressure and Evolution Induced by Immune Checkpoint Inhibitors and Other Immunologic Therapies

Active, not recruitingOBSERVATIONAL

Enrollment

14

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions

Head and Neck CancerMelanoma

All Listed Sponsors

collaborator

Princess Margaret Hospital, Canada

OTHER

lead

University Health Network, Toronto

OTHER